PT2376499E - Sal citrato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa- 5,7,26-triaza-tetraciclo[19.3.1.1(2,6)1(8,12)]heptacosa- 1(25),2(26),3,5,8,10,1 (27),16,21,23-decaeno - Google Patents

Sal citrato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa- 5,7,26-triaza-tetraciclo[19.3.1.1(2,6)1(8,12)]heptacosa- 1(25),2(26),3,5,8,10,1 (27),16,21,23-decaeno Download PDF

Info

Publication number
PT2376499E
PT2376499E PT97886212T PT09788621T PT2376499E PT 2376499 E PT2376499 E PT 2376499E PT 97886212 T PT97886212 T PT 97886212T PT 09788621 T PT09788621 T PT 09788621T PT 2376499 E PT2376499 E PT 2376499E
Authority
PT
Portugal
Prior art keywords
heptacosa
tetracyclo
triaza
dioxa
pyrrolidin
Prior art date
Application number
PT97886212T
Other languages
English (en)
Inventor
Cheng Hsia Angeline Lee
Anthony Deodaunia William
Brian Dymock
Original Assignee
Cti Biopharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cti Biopharma Corp filed Critical Cti Biopharma Corp
Publication of PT2376499E publication Critical patent/PT2376499E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/22Tricarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D201/00Preparation, separation, purification or stabilisation of unsubstituted lactams
    • C07D201/02Preparation of lactams
    • C07D201/10Preparation of lactams from cycloaliphatic compounds by simultaneous nitrosylation and rearrangement
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
PT97886212T 2008-12-11 2009-12-09 Sal citrato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa- 5,7,26-triaza-tetraciclo[19.3.1.1(2,6)1(8,12)]heptacosa- 1(25),2(26),3,5,8,10,1 (27),16,21,23-decaeno PT2376499E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12166808P 2008-12-11 2008-12-11

Publications (1)

Publication Number Publication Date
PT2376499E true PT2376499E (pt) 2015-06-03

Family

ID=41666397

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97886212T PT2376499E (pt) 2008-12-11 2009-12-09 Sal citrato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa- 5,7,26-triaza-tetraciclo[19.3.1.1(2,6)1(8,12)]heptacosa- 1(25),2(26),3,5,8,10,1 (27),16,21,23-decaeno

Country Status (24)

Country Link
US (2) US8980873B2 (pt)
EP (1) EP2376499B1 (pt)
JP (1) JP5669748B2 (pt)
KR (1) KR101729918B1 (pt)
CN (1) CN102282148B (pt)
AR (2) AR074724A1 (pt)
AU (1) AU2009325147B2 (pt)
BR (1) BRPI0922736B1 (pt)
CA (1) CA2746058C (pt)
DK (1) DK2376499T3 (pt)
ES (1) ES2536558T3 (pt)
HK (1) HK1161877A1 (pt)
HR (1) HRP20150428T1 (pt)
IL (3) IL213418A0 (pt)
MX (1) MX2011006206A (pt)
MY (1) MY160005A (pt)
NZ (1) NZ593223A (pt)
PL (1) PL2376499T3 (pt)
PT (1) PT2376499E (pt)
RU (1) RU2527970C2 (pt)
SG (1) SG171907A1 (pt)
TW (1) TWI449705B (pt)
WO (1) WO2010068181A1 (pt)
ZA (1) ZA201104032B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5669748B2 (ja) 2008-12-11 2015-02-12 シーティーアイ・バイオファーマ・コーポレーションCTI BioPharma Corp. 11−(2−ピロリジン−1−イル−エトキシ)−14,19−ジオキサ−5,7,26−トリアザ−テトラシクロ[19.3.1.1(2,6).1(8,12)]ヘプタコサ−1(25),2(26),3,5,8,10,12(27),16,21,23−デカエンクエン酸塩
US8987243B2 (en) * 2008-12-11 2015-03-24 Cti Biopharma Corp. 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt
KR101673979B1 (ko) 2012-04-13 2016-11-08 리안윤강 진강 해신 파머수티컬 코. 엘티디. 화합물 jk12a 및 그 제조
CN105061467B (zh) * 2015-08-28 2017-08-25 苏州立新制药有限公司 一种帕克替尼的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728536A (en) 1993-07-29 1998-03-17 St. Jude Children's Research Hospital Jak kinases and regulation of Cytokine signal transduction
US6136595A (en) 1993-07-29 2000-10-24 St. Jude Children's Research Hospital Jak kinases and regulations of cytokine signal transduction
JP4137645B2 (ja) * 2001-05-14 2008-08-20 ファイザー・プロダクツ・インク 5,8,14−トリアザテトラシクロ[10.3.1.02,11.04,9]−ヘキサデカ−2(11),3,5,7,9−ペンタンのクエン酸塩及びその医薬組成物
US6433018B1 (en) 2001-08-31 2002-08-13 The Research Foundation Of State University Of New York Method for reducing hypertrophy and ischemia
ES2258652T3 (es) * 2001-11-29 2006-09-01 Pfizer Products Inc. Sales de succinato de 5,8,14-triazatetraciclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de los mismos.
WO2007058628A1 (en) * 2005-11-16 2007-05-24 S*Bio Pte Ltd Heteroalkyl linked pyrimidine derivatives
JP5669748B2 (ja) 2008-12-11 2015-02-12 シーティーアイ・バイオファーマ・コーポレーションCTI BioPharma Corp. 11−(2−ピロリジン−1−イル−エトキシ)−14,19−ジオキサ−5,7,26−トリアザ−テトラシクロ[19.3.1.1(2,6).1(8,12)]ヘプタコサ−1(25),2(26),3,5,8,10,12(27),16,21,23−デカエンクエン酸塩

Also Published As

Publication number Publication date
BRPI0922736B1 (pt) 2022-02-22
PL2376499T3 (pl) 2015-07-31
KR20110106344A (ko) 2011-09-28
US20150322084A1 (en) 2015-11-12
TW201028426A (en) 2010-08-01
US20110294831A1 (en) 2011-12-01
BRPI0922736A8 (pt) 2021-11-09
AU2009325147A1 (en) 2011-06-23
BRPI0922736A2 (pt) 2017-10-31
ZA201104032B (en) 2012-08-29
MX2011006206A (es) 2011-07-20
NZ593223A (en) 2013-08-30
RU2011126173A (ru) 2013-01-20
CA2746058A1 (en) 2010-06-17
AU2009325147B2 (en) 2014-08-14
JP2012511571A (ja) 2012-05-24
AR074724A1 (es) 2011-02-09
WO2010068181A1 (en) 2010-06-17
AR114133A2 (es) 2020-07-22
DK2376499T3 (en) 2015-05-04
MY160005A (en) 2017-02-15
SG171907A1 (en) 2011-07-28
TWI449705B (zh) 2014-08-21
IL250310A0 (en) 2017-03-30
WO2010068181A8 (en) 2011-08-18
HRP20150428T1 (en) 2015-06-19
CA2746058C (en) 2016-05-17
CN102282148B (zh) 2014-12-24
JP5669748B2 (ja) 2015-02-12
US8980873B2 (en) 2015-03-17
EP2376499A1 (en) 2011-10-19
CN102282148A (zh) 2011-12-14
US9624242B2 (en) 2017-04-18
EP2376499B1 (en) 2015-02-25
IL213418A0 (en) 2011-07-31
RU2527970C2 (ru) 2014-09-10
IL289379A (en) 2022-02-01
HK1161877A1 (en) 2012-08-10
ES2536558T3 (es) 2015-05-26
KR101729918B1 (ko) 2017-04-25

Similar Documents

Publication Publication Date Title
HUS1800031I1 (hu) Dioxa-biciklo[3.2.1.]oktán-2,3,4-triol származékok
IL289379A (en) Citrate salt of 11-(2-pyrrolidin-1-yl-ethoxy)-19,14-dioxa-26,7,5-triaza-tetracyclo[1.1.3.19(6,2)1(12,8)]hepatacosa- 1(25),2(26),12,10,8,5,3(27)j23,21,16–Decan
IL242665B (en) Processes for preparing anti-tricyclo[3.2.2.0]non-6-ene-endo-8,endo-9-dicarboxylic acid anhydride
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
IL213787A0 (en) Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
PL2013208T3 (pl) Pirydyno[3,4-B]pirazynowy
ZA201006732B (en) 2-aza-bicyclo[2.2.1]heptane derivatives
IL188431A0 (en) Process for preparing 3-arylmethylthio-and 3-heteroarylmethylthio-4,5-dihydro-
HRP20150413T8 (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
HK1178159A1 (en) 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22- nonaene citrate salt 9e-15-(2--1--)-71225--192124-- [18311(25)1(1418)]-1(24)249141618(26)20 22-
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL206668A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL200166A0 (en) New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6h)-one
IL187673A0 (en) Process for preparing 3,3-diarylpropylamines
HK1151801A1 (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid
ZA201101961B (en) Method for preparing 1,6:2,3-dianhydro-beta-d-mannopyranose
TH0901005537B (th) 11-(2-ไพร์โรลิดิน-1-อิล-เอทอกซี)-14,19-ไดออกซา-5,7,26-ไตรอะซา-เตตราไซโคล[19.3.1.1(2,6).1(8,12)]เฮปทาโคซา-1(25),2(26),3,5,8,10,12(27),16,21,23-เดคาอีน มาลีเอท ซอลท์
IL198203A0 (en) Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
IL180493A (en) Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
PL392579A1 (pl) Nowy związek 7,7-dimetylo-3,4-epoksy-8-oksabicyklo[4.3.0]nonan-9-on i sposób jego otrzymywania